Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

CFAP74-mutations as cause of Primary Ciliary Dyskinesia (PCD): Clinical presentation and diagnostic challenges

L Biebach, S Cindric, J Koenig, I Aprea, G Dougherty, J Raidt, D Bracht, R Ruppel, J Schreiber, R Hjeij, H Olbrich, H Omran
European Respiratory Journal 2022 60: 4522; DOI: 10.1183/13993003.congress-2022.4522
L Biebach
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Cindric
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Koenig
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I Aprea
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Dougherty
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Raidt
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Bracht
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Ruppel
2Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Schreiber
3Department of Pneumology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R Hjeij
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Olbrich
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Omran
1Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Challenges in diagnosing PCD include the underrecognition of the disease, the broad spectrum of clinical airway disease and the still ongoing identification of disease causing genes. CFAP74 encodes for a central pair associated protein. CFAP74 mutations were recently published as the cause of multiple morphological abnormalities of sperm flagella (MMAF), but respiratory cilia were not investigated.

The aim of our study was to establish whether CFAP74 mutations cause PCD.

PCD-candidate patients were screened for CFAP74-mutations. Additionally to diagnostic workup including clinical characterization, nasal NO measurement, high-speed video microscopy analysis (HSVMA), high-resolution immunofluorescence (IF) microscopy and transmission electron microscopy (TEM), we cultured respiratory cells, performed Western Blot analyses and particle tracking analyses in affected CFAP74 individuals.

In our PCD-cohort we identified three individuals from two families with compound heterozygous loss-of-function mutations in CFAP74. Western blot analyses proved the missing expression of CFAP74. All patients presented with a respiratory phenotype of varying degree. Interestingly, nasal NO production rates and TEM analyses showed normal results. HSVMA identified subtle ciliary beat abnormalities. The mucociliary clearance capacity, characterized by a fluid flow over the epithelial surface under air-liquid interface condition, was impaired.

Mutations in CFAP74 can cause PCD with subtle ciliary beating defects and impaired mucociliary clearance. As the affected present normal nasal NO levels and ciliary ultrastructure, genetic testing including CFAP74 is essential in the diagnostic workup for PCD.

  • Chronic diseases
  • Bronchiectasis
  • Genetics

Footnotes

Cite this article as Eur Respir J 2022; 60: Suppl. 66, 4522.

This article was presented at the 2022 ERS International Congress, in session “-”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2022
Previous
Back to top
Vol 60 Issue suppl 66 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
CFAP74-mutations as cause of Primary Ciliary Dyskinesia (PCD): Clinical presentation and diagnostic challenges
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
CFAP74-mutations as cause of Primary Ciliary Dyskinesia (PCD): Clinical presentation and diagnostic challenges
L Biebach, S Cindric, J Koenig, I Aprea, G Dougherty, J Raidt, D Bracht, R Ruppel, J Schreiber, R Hjeij, H Olbrich, H Omran
European Respiratory Journal Sep 2022, 60 (suppl 66) 4522; DOI: 10.1183/13993003.congress-2022.4522

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
CFAP74-mutations as cause of Primary Ciliary Dyskinesia (PCD): Clinical presentation and diagnostic challenges
L Biebach, S Cindric, J Koenig, I Aprea, G Dougherty, J Raidt, D Bracht, R Ruppel, J Schreiber, R Hjeij, H Olbrich, H Omran
European Respiratory Journal Sep 2022, 60 (suppl 66) 4522; DOI: 10.1183/13993003.congress-2022.4522
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Biomarker identification to assess effects of bone-marrow derived mesenchymal stromal cell-therapy in emphysema through immune profiling
  • Ex vivo modelling of human lung fibrogenesis and drug mode of action screens using single-cell RNA-seq in precision-cut lung slices
  • Airway morphogenesis in wild type and heterozygous F508del mouse embryonic lungs treated by Elexacaftor/Tezacaftor/Ivacaftor
Show more 03.03 - Mechanisms of lung injury and repair

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society